Operating profit before amortization: cogrx.com (CGTX)
The reliability of Cognition Therapeutics (CGTX) is based on robotic IT analysis of synaptic proteins. The size of cash EBITDA confirms the effectiveness of this strategy, while 0.00 reflects the latest level of the metric. Additional stability is provided by partnerships with gerontology centers fighting Alzheimer's and the proficient management of contract research organizations to conduct clinical trials.
%20Operating%20profit%20EBITDA&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_CGTX_-_Cognition-Therapeutics_-_Operating-profit-EBITDA "cogrx.com - CGTX Operating income before deduction of amortization (period 11/23/2025 - 11/14/2026) | 👁️GURU.Markets👁️")
Summary analytical data breakdowns for Cognition Therapeutics (CGTX)
- price and consensus price forecast:
- company stock exchange capitalization indicators:
- balance sheet net asset value indicators:
- business debt structure and liquidity details:
Total Debt to Capital Coefficient Cognition Therapeutics|CGTX - Long-Term Debt to Equity|Current Liabilities to Capital cogrx.com|CGTX - Company Debts|Debt to Book Value Ratio Cognition Therapeutics|CGTX - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Cognition Therapeutics|Intermediate Liquidity Ratio cogrx.com
- company profitability and valuation multiples indicators:
CGTX - Net Profit|Expected Net Income Cognition Therapeutics|CGTX - P/E Multiple|Projected Price to Earnings Ratio Cognition Therapeutics Inc.|CGTX - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation Cognition Therapeutics|CGTX - Operating profit EBITDA|Net earnings per share (EPS TTM) Cognition Therapeutics|CGTX - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months cogrx.com|CGTX - Earnings growth in current year|Expected net earnings per share growth next year Cognition Therapeutics
- sales and revenue indicators:
Analysis of all company metrics:Cognition Therapeutics Inc. - CGTX
This indicator determines the business's actual ability to generate cash flow from core operations, excluding non-cash charges and tax adjustments. Analyzing EBITDA allows for an assessment of the effectiveness of Cognition Therapeutics (CGTX) investments in the development of Alzheimer's disease drugs and the cost of its research and development collaborations with specialized aging institutes.
Competitor analysis for Cognition Therapeutics
Operating profit before depreciation charges Biogen Idec|NBIX - Profit before payment of interest, taxes and amortization|RGC (regencellbioscience.com) - Operating profit before amortization|AXSM: Operating profit EBITDA|ACAD - Operating income before deduction of amortization|Operating profit before deduction of amortization XENE|VKTX (Viking Therapeutics Corp) - Company profit before taxes, interest and amortization|Operating profit EBITDA SUPN|Operating income before deduction of amortization catalystpharma.com|Profit before payment of interest, taxes and amortization Denali Therapeutics Inc. DNLI|Harmony Biosciences Inc (HRMY) - Profit before interest, taxes and amortization|BHVN - Profit before payment of interest, taxes and amortization|AMLX (Amylyx Corp) - Operating profit before amortization|TRVI (Trevi Therapeutics) - Operating profit before deduction of amortization|praxismedicines.com - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization AVXL|CBLL (CeriBell Inc) - Company profit before taxes, interest and amortization|Operating profit EBITDA PRTA|ALEC (alector.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA ANNX (Annexon, Inc.)|Omeros Corp (OMER) - Profit before interest, taxes and amortization|NGNE - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization ACIU (AC Immune S.A.)|VYGR: Operating profit EBITDA|Neumora Corp (NMRA) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Scilex Holding Company|tevogen.com - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA ACOG|IKT - Profit before interest, taxes and amortization|Cassava - Operating profit before deduction of amortization|Operating profit EBITDA Assertio Holdings ASRT|COYA: Operating profit before deduction of amortization|Vistagen Therapeutics - Company profit before taxes, interest and amortization|OVID: Operating profit EBITDA|ABOS - Operating income before deduction of amortization|CRVO (CervoMed Inc) - Operating profit EBITDA|Operating profit before deduction of amortization Alterity Therapeutics Ltd (ATHE)|Profit before payment of interest, taxes and amortization Clene Inc. (CLNN)|Operating income before deduction of amortization pepgen.com|Operating profit EBITDA JUNS (Jupiter Neurosciences)|RLMD - Operating profit before deduction of amortization|Annovis Bio Corp - Operating profit EBITDA|Operating profit before depreciation charges Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuroscience, Inc) - Operating profit before deduction of amortization|KLTO: Company profit before taxes, interest and amortization|Operating profit before deduction of amortization NRSN|Operating profit before amortization RVPH (Reviva Pharmaceuticals Holdings Inc.)|Profit before payment of interest, taxes and amortization MetaVia Inc (MTVA)|NeurAxis Inc - Operating profit before amortization|Operating profit EBITDA HSDT (Helius Medical Technologies)|Passage Bio Inc. (PASG) - Profit before interest, taxes and amortization|NEUP: Operating profit before deduction of amortization|NERV - Operating profit EBITDA|Athira (ATHA) - Profit before payment of interest, taxes and amortization|Addex - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Alzamend Neuro Inc.|Profit before interest, taxes and amortization Cyclerion CYCN|Operating profit EBITDA PTIX|Operating profit before deduction of amortization pasitheaclinics.com KTTA|Profit before payment of interest, taxes and amortization Cortigent CRGT|Avenue Therapeutics Inc (ATXI) - Profit before interest, taxes and amortization|Brainstorm Cell - Operating profit EBITDA|Operating profit before depreciation charges caratherapeutics.com (CARA)|Chromocell Therapeutics Corp. (CHRO) - Profit before payment of interest, taxes and amortization|Operating profit before amortization ELYM|ITCI (Intra-Cellular Therapies Inc.) - Operating profit EBITDA|Longboard (LBPH) - Operating income before deduction of amortization|Operating profit before deduction of amortization MRNS (Marinus Pharmaceuticals)|Company profit before taxes, interest and amortization NKGN|Operating profit EBITDA NRBO (NeuroBo Pharmaceuticals, Inc.)|Operating income before deduction of amortization Sage Therapeutics Inc. (SAGE)|SNPX - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Trevena Inc|vigilneuro.com (VIGL) - Profit before payment of interest, taxes and amortization|Operating profit before amortization WENA|Operating profit before deduction of amortization CERE
